Added to YB: 2026-08-07
Pitch date: 2026-08-05
ZTS [bullish]
Zoetis Inc.
-1.97%
current return
Author Info
No bio for this author
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Market Cap
$31.2B
Pitch Price
$78.82
Price Target
118.00 (+59%)
Dividend
N/A
EV/EBITDA
9.30
P/E
12.14
EV/Sales
N/A
Sector
Pharmaceuticals
Category
value
The Animal Kingdom's Toll Booth: Inside Zoetis
ZTS: Largest pure-play animal health co, 11% of $78B market, $9.5B rev (+6% organic), 26.5% ROIC vs 7.4% WACC (19.1pt spread). Stock -50% from 2024 highs on Librela/Solensia adoption noise (US Librela -32% Q4). Base case IV $118 vs $76 (0.65x P/V, 55% upside); bear $87, bull $158. Catalysts: Lenivia/Portela 3-mo dosing rollout 2026, pet insurance/diagnostics expansion. Wide moat: regulatory, switching costs, scale. 10% Portfolio A sizing. Options: sell Jan27 $70 puts ($5.40, $64.60 entry) or buy 80/100 call spread.
Read full article (13 min)